Navigation Links
Immune Function in Adult Heart Transplant Patients Reflects Risk for Organ Rejection and Infection
Date:4/11/2008

(average CMI = 438 ng/mL ATP) than the average measure among patients showing no signs of rejection (average CMI = 301 ng/mL ATP; p = 0.05).

The analysis also looked at the incidence of infections among the study population. A total of 30 infections were identified in patients with low CMI (<225 ng/mL ATP; based on 57 assays) as compared to only eight infections in patients with moderate or strong CMI (>225 ng/mL ATP; based on 113 assays). The average CMI in samples from patients with infection was 119 ng/mL ATP as compared to 336 ng/mL ATP in samples from patients with no sign of infection (p < 0.001). Identified infections included 13 with a viral etiology; 15 with bacterial etiology; and 10 with fungal etiology.

"Immune function monitoring of adult heart transplant patients using the ImmuKnow assay may have the potential to aid in the assessment of the immune status of the patient and the patient's risk for organ rejection or infection," concluded Dr. Kobashigawa. "We are currently conducting clinical studies using these data to manage immunosuppression in our heart transplant patients, with the goal of limiting risk for rejection and infection."

Dr. Kobashigawa's presentation was entitled, "Success of immune monitoring with ImmuKnow (Cylex(TM)) to assess rejection/infectious risk in heart transplantation." Dr. Kobashigawa is Clinical Professor of Medicine and Chief of the Division of Clinical Faculty Medicine at David Geffen School of Medicine at UCLA. He is also Medical Director of the UCLA Heart Transplant Program.

About ImmuKnow(R)

ImmuKnow is an immune cell function assay that can detect cell-mediated immunity (CMI) in adult immunosuppressed patients by measuring the concentration of adenosine triphosphate (ATP) released from CD4 cells following cell stimulation.

The ImmuKnow test is a qualitative assay and does not directly quantify the level of immunosuppression. Results of ImmuKnow assays should be used in conjunc
'/>"/>

SOURCE Cylex Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research
2. Immune Tolerance Institute Appoints Aaron B. Kantor Ph.D. Chief Scientific Officer
3. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
4. Seneca Valley High School Student Receives Science Award From MedImmune
5. Oncolytics Biotech Inc. Announces Publication of Research on Immune Response to REOLYSIN(R) during a Phase I Clinical Trial
6. AutoImmune Inc. Reports 2007 Fourth Quarter and Year End Financial Results
7. ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
8. Immune system protein starves staph bacteria
9. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
10. MedImmune Submits Biologics License Application to FDA for Motavizumab
11. Peptimmune Announces First Close of Series D Private Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Pipette.com has added the Eppendorf ... portfolio of Eppendorf products. , The Eppendorf Centrifuge 5424/5424 ... 5424/5424 R and receive the following:, , ... or Eppendorf Reference 2 ,     3 Free ...
(Date:1/22/2015)... Geneva, Switzerland (PRWEB) January 22, 2015 ... for characterized mammalian Research Cell Banks (RCBs) used for ... generated Research Cell Banks will include Next-Generation Sequencing ... cell’s genetic architecture de-risks biologic manufacturing by ensuring the ...
(Date:1/22/2015)... ALTO, Calif. , Jan. 22. 2015  Varian Medical Systems ... and software, has been honored for its commitment to sustainability ... sustainable companies. Varian is the highest ranked healthcare equipment company ... announced today during the World Economic Forum at ...
(Date:12/24/2014)... 24, 2014  United Therapeutics Corporation (NASDAQ: UTHR ... MDT ) has submitted a pre-market approval application to ... use of Medtronic,s SynchroMed ® II implantable drug ... with United Therapeutics, Remodulin ® (treprostinil) Injection delivered ...
Breaking Biology Technology:Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... Calif., Aug. 24 BioPharm Systems, a leading provider ... that it has been named to Inc. magazine,s list ... for 2010. The Inc. 500|5000 ranks companies by overall ... recognized for its 60 percent three-year growth rate. ...
... Aug. 24 Catholic Health Initiatives, (CHI) Institute ... and BioFortis, Inc. have announced a joint strategic ... healthcare initiatives for community hospitals across their system. ... (CTR) is a clinical R&D and molecular diagnostics ...
... Aug. 24 The US Center for Disease Control and Prevention ... due to the common cold and on average children have between ... your child is sick all the time? In the early school ... all, young children in large groups are breeding grounds for the ...
Cached Biology Technology:BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S. 2BioFortis and Catholic Health Initiatives' Center for Translational Research Announce Biorepository Information Technology Strategic Partnership to Drive Progress in Personalized Medicine 2BioFortis and Catholic Health Initiatives' Center for Translational Research Announce Biorepository Information Technology Strategic Partnership to Drive Progress in Personalized Medicine 3Back To School: Staying Healthy at School is as Easy as Learning Your ABC's 2Back To School: Staying Healthy at School is as Easy as Learning Your ABC's 3Back To School: Staying Healthy at School is as Easy as Learning Your ABC's 4
(Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading ... the launch of its new website design. "When ... its infancy", says Peter O,Neill , founder and CEO ... the industry needs involvement from the key players on a ...
(Date:1/22/2015)... 2015 Technology Showcase, Hall E -   EyeLock Inc. ... announced it will showcase its EyeLock ID technology integrated in ... of Energy,s Oak Ridge National Laboratory (ORNL) at ... iris identity authentication technology is being used to validate the ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of insulin ... other mental capabilities in adults with mild cognitive impairment ... led by researchers at Wake Forest Baptist Medical Center. ... with amnesic mild cognitive impairment (MCI) or mild to ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... push and pull on each other, and they must ... Now scientists at Harvard University have devised the first ... and living embryos. The method, which involves injecting tiny ... cancer, hypertension, connective tissue diseases, and more. Scientists from ...
... This news release is available in German . ... for Chemical Ecology in Jena, Germany, have discovered the decisive biological ... used by the insects to fend off predators: ABC transport proteins, ... larvae. The poplar leaf beetle Chrysomela populi is able ...
... Calif. , Dec. 9, 2013   Life Technologies ... Centre for DNA Barcoding in support of the Centre,s ... study that will genetically sequence and catalogue 5 million ... DNA-based approaches are playing a crucial role in helping ...
Cached Biology News:Measuring life's tugs and nudges 2Measuring life's tugs and nudges 3ABC transporters enable leaf beetle larvae to accumulate defensive precursors when feeding 2ABC transporters enable leaf beetle larvae to accumulate defensive precursors when feeding 3Life Technologies Collaborates with Canadian Centre for DNA Barcoding on Species Biodiversity Study 2Life Technologies Collaborates with Canadian Centre for DNA Barcoding on Species Biodiversity Study 3Life Technologies Collaborates with Canadian Centre for DNA Barcoding on Species Biodiversity Study 4
... DMW143 taken from the SMZ line is a ... production and testing. It is available with a ... or a space-saving compact base (N2GG). This microscope ... and a projector all at the same time ...
... Reagent optimized for siRNA applications, contains magnetic ... the nucleic acid of interest. Exploiting magnetic ... then rapidly drawn towards and delivered into ... MATra-si Reagent can be used for adherent ...
...
... The TNT Coupled Reticulocyte Lysate Systems(a,b,c,d) ... in vitro translations: a single-tube, coupled ... greatly simplify the process and reduce ... vitro translation results. Standard rabbit reticulocyte ...
Biology Products: